Cardiovascular risks of androgen receptor targeted agents in prostate cancer: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Cardiovascular risks of androgen receptor targeted agents in prostate cancer: a systematic review and meta-analysis

Published:2024-01-24 Issue:3 Volume:27 Page:393-403
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Ong Chloe Shu Hui^ORCID,Law Yu Xi Terence^ORCID,Kyaw Lin,Lim Qi Yang,Loke Tim,Wu Qing Hui,Tiong Ho Yee^ORCID,Chiong Edmund

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41391-024-00792-5.pdf

Reference48 articles.

1. International W Prostate cancer statistics London: World Cancer Research Fund International; 2022 [updated 23 March 2022. Available from: https://www.wcrf.org/cancer-trends/prostate-cancer-statistics/.

2. Montgomery RB, Mostaghel EA, Vessella R, Hess DL, Kalhorn TF, Higano CS, et al. Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth. Cancer Res. 2008;68:4447–54.

3. Fizazi K, Tran N, Fein L, Matsubara N, Rodriguez-Antolin A, Alekseev BY, et al. Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial. Lancet Oncol. 2019;20:686–700.

4. Armstrong AJ, Szmulewitz RZ, Petrylak DP, Holzbeierlein J, Villers A, Azad A, et al. ARCHES: a randomized, phase III study of androgen deprivation therapy with enzalutamide or placebo in men with metastatic hormone-sensitive prostate cancer. J Clin Oncol. 2019;37:2974–86.

5. Smith MR, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, et al. Darolutamide and health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the phase III ARAMIS trial. Eur J Cancer. 2021;154:138–46.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular risks of Asian patients on androgen-receptor-targeted agents for prostate cancer: a systematic review and meta-analysis;Prostate International;2024-08

2. Cardio-oncology in advanced prostate cancer;Frontiers in Oncology;2024-06-14